Hester Biosciences Ltd — Quarterly Results & Earnings

₹1259.10

-4.49%

Profit Growth YoY76.22%Latest quarter

Sales Growth YoY-15.20%Latest quarter

Sales CAGR 5Y11.16%5 year compound

Profit CAGR 5Y-0.72%5 year compound

📋

Quarterly Performance

YoY Profit Growth+76.22%

🔥 Exceptional growth

YoY Sales Growth-15.20%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

22.12%

EPS Growth 5Y

-0.72%

Interest Coverage

Higher = safer debt servicing

10.32

ROE

9.18%

ROCE

9.71%

💡

Growth Analysis

Hester Biosciences Ltd reported YoY profit growth of 76.22% and revenue growth of -15.20% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 11.16% and profits at -0.72% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Hester Biosciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.